Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

The UFS produces some of the finest teachers in the country
2015-03-02

 

The quest for producing well-grounded, excellent and prolific teachers at the UFS is bearing fruit. Numerous accolades have over the years been bestowed on some of the UFS Qwaqwa Campus's finest graduates.

"For us as the faculty, it is gratifying and rewarding to learn about the achievements of our students. These achievements do not only validate our efforts, but inspire us as well,” says Dr Dipane Hlalele, Assistant Dean in the Faculty of Education at the UFS.

Dr Hlalele also revealed that, in the recent past, the faculty at the Qwaqwa Campus has experienced an increase in the enrolment figures for teacher training.

"Numbers in our initial teacher education programmes grow in leaps and bounds and we produce some of the best teachers in the country. We are proud to say that on graduation day, our students receive at least two things, i.e., their qualifications as well as entry into the teaching profession," added Hlalele.

Some of the shining examples that Dr Hlalele referred to, are Tebello Tshabalala (English), Mthobisi Khumalo (Mathematics), Thabo Mohapi (Physical Sciences), Lehlohonolo Khanye (Accounting) and Yvonne Tsotetsi (Business Studies). All of these are educators at Lekgulo Senior Secondary School in Qwaqwa and have each produced a 100% pass rate in the 2014 examinations.

There is also Nape Motloung, whose excellent Mathematics results at Botshabelo's Lefikeng High School have placed him as the Top Mathematics Educator in the Free State. Motloung's consistent excellent results have also placed his school in the Top 10 of the Best Performing Schools in Mathematics. This has also won his school R100 000 from the Free State Department of Education.

At yet another Qwaqwa school, Sekgutlong Secondary, Malefetsane Mokomotoane's Mathematics results over the years have earned him a runner-up prize in the category Excellence in Teaching Mathematics at the 2014 National Teachers Awards hosted by Minister Angie Motshekga.

"I am proud to have had 98% of my learners pass Mathematics, with 10 distinctions," said an elated Mokomotoane, who has just been appointed Principal of Selelekela Secondary School in Qwaqwa.

"Having achieved an average of 59%, my highest ever, has taught me and my learners that through hard work, anything is possible," added Mokomotoane.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept